Overview


The global market is predicted to witness a surge as there is a rise in the occurrences of cancer, favorable sanctions by global health and government organizations along with a greater tendency to opt for diagnostic procedures which are minimally invasive. Biopsy performed on the breast involves the removal of tissues and cells in certain areas of the breast that are vulnerable to diseases such as cancer. These tissues and cells are examined under a microscope to identify potential chances of cancer. When a hollow needle is inserted for the purpose of removing tissue samples from the breast, then it is called a core needle biopsy. Core needle biopsy is carried out for the detection of any lump or mass or any other suspicious spots which is identified after imaging testing or mammogram. In the case of biopsy that entails fine needles, there is also a removal of cells potentially cancerous lumps in the breast. The needle that is used for performing the fine needle biopsy happens to be thinner in comparison to the needle used in the biopsy of the core needle. There are different kinds of biopsies which includes vacuum-assisted biopsy, core needle biopsy, shave biopsy, image guided biopsy, punch biopsy, excisional biopsy, incisional biopsy, fine needle aspiration, endoscopic biopsy, bone marrow biopsy and bone marrow aspiration. Two primary types of biopsies are surgical biopsy and needle biopsy. Surgical biopsy entails an incision to gather tissue samples and core needle biopsy is carried out in either hospitals and imaging centers. This biopsy is an image guided process. There are many benefits associated with such biopsies as the possibilities of sustaining an infection or a bruise are less. In case the lump is shown to be benign, then surgical biopsy will not be required. Although, there is a risk that the needle may not detect the tumor cells and as a result, one could misconstrue this as a non-cancerous cell.
Going by the segmentation of product, the market has been bifurcated into aspiration and biopsy needles. The segment for biopsy needles is anticipated to thrive at a very high CAGR during the forecast time frame because of the high presence of cancer and initiatives undertaken by certain healthcare facilities.
With end users, the market is fragmented into academic institutes, hospitals, research laboratories, imaging and diagnostic centers. The segment for hospital is projected to grow, in part, because of the developing healthcare framework in emerging nations, which shall inflate the aspiration and biopsy needles market size.
Conmed Corporation, Medtronic Plc, Olympus, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Argon Medical Devices, Inc, INRAD Inc., Somatex Medical Technologies, Stryker Corporation.
By Product Type
Biopsy Needles
CNB Needles
VAB Needles
Aspiration Needles
By Procedure
Image-Guided Procedures
Non Image-Guided Procedures
By Site
Breast
Lung
Colorectal
Prostate
Kidney
Bone and Bone Marrow
Other Sites
By End User
Hospitals
Research
Academic Institutes
Diagnostic and Imaging Centers
By Region
Europe
North America
Asia Pacific
Latin America
Middle East
Africa
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth
To provide with an exhaustive analysis on the global aspiration
biopsy needles market by product type, by procedure, by site, by end user and by region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East
Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market
We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aspiration and Biopsy Needles Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Aspiration and Biopsy Needles Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aspiration and Biopsy Needles Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aspiration and Biopsy Needles Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aspiration and Biopsy Needles Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Biopsy Needles
         1.1. CNB Needles
         1.2. VAB Needles
        2. Aspiration Needles
  • 8.   Aspiration and Biopsy Needles Market, By Site Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Kidney
        6. Bone and Bone Marrow
        7. Others Sites
  • 9.   Aspiration and Biopsy Needles Market, By Procedure Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Image-guided Procedures
        2. Nonimage-guided Procedures
  • 10.   Aspiration and Biopsy Needles Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitals
        2. Research
      Academic Institutes
        3. Diagnostic and Imaging Centers
  • 11.   North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 12.   Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 13.   Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 14.   Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 15.   Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.1. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   17.1 . Conmed Corporation
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        17.2 . Medtronic Plc
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        17.3 . Becton
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        17.4 . Dickinson and Company
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        17.5 . Boston Scientific Corporation
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        17.6 . Cook Group Incorporated
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        17.7 . Argon Medical Devices, Inc
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
         17.8 . Inrad Inc.
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        17.9 . Somatex Medical Technologies
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
  • 18.  10 Stryker Corporation
    •    17.10.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.10.2. Product Portfolio
         17.10.3. SWOT Analysis
         17.10.4. Financial Overview
         17.10.5. Strategic Overview
  • 19.   Pre and Post COVID-19 Impact
    •   18.1. Positive influence on the healthcare industry
        18.2. The financial disruption of the manufacturing sector
        18.3. Impact of COVID-19 on emerging companies
        18.4. Significant mandates in the healthcare regulations initiated by administrations
        18.5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients